Directed new share issue in CELLINK AB (SE) — SEK 148.5 million

Carnegie acted as sole bookrunner in the directed new share issue of 550,000 new shares at a subscription price of SEK 270.00 per share. CELLINK is the leading 3D-bioprinter provider and bioink company in the world. June 2019.